Ortho-clinical reagents for transfusion medicine

Ended Purchase Order Awarded

Contract number
75N90023P00244
Awardee
Awarding agency
Obligated
$92,436

Award facts

Contract value 100% obligated
$92,436.37 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Ortho-Clinical Diagnostics, Inc. for ortho-clinical reagents for transfusion medicine. The contract has a ceiling value of $92,436.37 and a period of performance ending on February 29, 2024.

Ortho-Clinical Diagnostics, Inc. is a medical equipment manufacturing company that provides diagnostic solutions, including products for blood banking and clinical chemistry. They have previously provided federal agencies such as the Department of Veterans Affairs and Department of Defense with laboratory equipment, reagents, and testing services under various contract vehicles. This award does not have a set-aside designation.

Quick answers

Who was awarded contract 75N90023P00244?

75N90023P00244 was awarded to Ortho-Clinical Diagnostics, Inc. by NIH Clinical Center (National Institutes of Health) on March 7, 2023.

How much is contract 75N90023P00244 worth?

The government has obligated $92,436 on 75N90023P00244.

Was contract 75N90023P00244 competed?

The extent of competition for 75N90023P00244 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award